iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
IBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -0.02%197.222.7%$113.78m
ARGXargenx SE 2.01%376.870.0%$86.41m
VRXValeant Pharmaceuticals International, Inc. 0.66%7.5914.1%$44.66m
BRBRBellRing Brands, Inc. -0.56%21.460.0%$19.79m
RVMDRevolution Medicines, Inc. -2.65%19.470.0%$17.67m
USNAUSANA Health Sciences, Inc. -2.10%56.964.2%$3.73m
ANIKAnika Therapeutics, Inc. 0.29%24.639.7%$2.19m
BGXXBright Green Corp. -1.95%0.980.0%$1.31m
IBIOiBio, Inc. -3.40%0.170.2%$0.47m
MTPMidatech Pharma Plc 7.65%2.110.0%$0.47m
ENVBEnveric Biosciences, Inc. -1.70%4.640.0%$0.40m
FLGCFlora Growth Corp. -8.22%0.670.0%$0.30m
NATRNature's Sunshine Products, Inc. -4.15%8.310.4%$0.29m
BPTSBiophytis SA -1.90%0.600.0%$0.26m
CDXCChromadex Corp. 0.74%1.362.7%$0.20m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics using its FastPharming Manufacturing System. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The Biopharmaceuticals segment includes the Therapeutics unit, which is focused on oncology as well as fibrotic and infectious diseases, and the Vaccines unit, which is focused on human and animal health vaccines. The Bioprocessing segment includes Services (FastPharming, Process Development, Manufacturing, as well as Bioanalytical and other services) and Products (growth factors, lectins, and monoclonal antibodies) for research and further manufacturing uses, collectively known as Research & Bioprocess products (RBP). The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in New York, NY.